Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3674064014 | Acamprosate calcium 333 mg gastro-resistant oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3674065010 | Product containing precisely acamprosate calcium 333 milligram/1 each gastro-resistant oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Is a | Acamprosate only product in oral dose form | true | Inferred relationship | Some | ||
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Is a | Acamprosate calcium | false | Inferred relationship | Some | ||
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Is a | Alcohol metabolism modifier | false | Inferred relationship | Some | ||
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Is a | Acamprosate calcium | false | Inferred relationship | Some | ||
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Has active ingredient | Acamprosate calcium | false | Inferred relationship | Some | ||
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Has active ingredient | Central nervous system agent | false | Inferred relationship | Some | ||
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Is a | Acamprosate-containing product | false | Inferred relationship | Some | ||
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Some | ||
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Some | ||
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Has manufactured dose form | Gastro-resistant oral tablet | true | Inferred relationship | Some | ||
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Has precise active ingredient | Acamprosate calcium | true | Inferred relationship | Some | 1 | |
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Has BoSS | Acamprosate calcium | true | Inferred relationship | Some | 1 | |
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Has presentation strength numerator value | 333 | false | Inferred relationship | Some | 1 | |
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Is a | Acamprosate-containing product in oral dose form | false | Inferred relationship | Some | ||
| Acamprosate calcium 333 mg gastro-resistant oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Description inactivation indicator reference set
FHIR